InvestorsHub Logo
Followers 784
Posts 128093
Boards Moderated 9
Alias Born 09/26/2011

Re: OtcChick post# 56772

Friday, 10/03/2014 10:16:09 AM

Friday, October 03, 2014 10:16:09 AM

Post# of 63283
$VRCI Verde Science Strengthens Scientific Team.. read the news

Published: Oct 2, 2014 9:01 a.m. ET

http://www.marketwatch.com/story/verde-science-strengthens-scientific-team-2014-10-02

Richmond, BC / ACCESSWIRE / October 2, 2014 / Verde Science, Inc. (VRCI-OTCQB) a Medical Marijuana Research and Development Company, is pleased to announce the expansion of its Research and Development capabilities with the addition of its newest alliance partners, Dr. Ratnesh Jain and Dr. Prajatka Dandekar Jain, both of whom earned their Ph.D.'s in Pharmacology from the Institute of Chemical Technology, a Mumbai, India based University with a research focus along the entire spectrum of Chemical Engineering. Dr. Ratnesh Jain has investigated the development and design of novel drug delivery mechanisms which we believe will have significant applications in the nascent field of Medical Marijuana treatment. This could also be applied to clinical trials aimed at determining proper dosing and drug formulations for various specific medical issues.

Dr. Prajakta Dandekar Jain is an Assistant Professor of Pharmaceutical Technology at the Institute of Chemical Technology. In addition to research into novel drug delivery systems, she has also focused much of her research on nanoparticles, which will have particular relevance in the study of medical uses of THC and cannabinoids, and nanoparticles of hemp. Harp Sangha, Verde's Chairman and CEO commented, "The addition of Drs. Jain to our current in-house R&D staff in Canada is going to be an immediate boost to our research program. It enables us to begin on research and clinical trials in India, which at the moment are on hold pending licensing in Canada. This gives Verde a huge advantage."

Verde's Research and Development Program will focus on developing custom medicinal formulations from cannabinoids and THC compounds for the treatment of specific issues such as migraines, glaucoma, loss of appetite from cancer therapies, and numerous other medical issues. Verde also plans to alpha test innovate growing technologies in India as part of the company's initiatives. (A more extensive background statement for the Drs. Jain is available on the Verde Science website: http://www.verdescienceinc.com/.)

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.